Human Genome Sciences, Inc.

University of Michigan

Snowflake Inc.

Other

James G Pan

Craig A Rosen

Jian Ni

Vishva M Dixit

Reiner L Gentz

Subramanian Muralidhar

Damien Carru

Unmesh Jagtap

Pui Kei Johnston Chu

Xiaodi Ke

Benoit Dageville

Steven Parkes

Iulia Ion

Tyson J Hamilton

Xie Xu

Rishabh Gupta

Ryan Charles Quistorff

Hrushikesh Shrinivas Paralikar

Jake Tsuyemura

Nihar Pasala

Haroldo Level

An anti-abuse system is provided for a data-platform. An anti-abuse scanner of the data-platform detects a creation of an application package by a provider of content to the data platform where the application package includes a set of files for deployment on the data platform. The anti-abuse scanner performs a review of the set of files to detect malicious content where the review is based on a set of analysis rules and generates a deployment decision for the application package based on a result of the review.

Application trust framework

Embodiments of the present disclosure provide a region-specific events account that is used as a central place to store the events shared by consumers of shared applications in that region. Use of such an account helps reduce the operational burden of a provider of the applications as they do not need to determine which accounts have shared events for each different consumer. The provider only needs to login to the events account which is in the same region as the consumer and can query all shared events from different applications that are being used in that region. Also, since the provider can designate an events account in each region, the shared events could be directly ingested into the events account without traveling to a different region.

Events account for native app event sharing

Disclosed is an execution information sharing system that duplicates execution information to a provider target (and other targets) as it is being loaded to a consumer target. A consumer account of a data sharing platform executes an application shared with it by a provider account of the platform. Consumer and provider configurations indicating consumer and provider targets respectively are generated. The consumer configuration and provider configurations are provided to an event context to generate a first and second event unloaders respectively, wherein the event context maintains a mapping linking both the first event unloader and the second event unloader to the application. In response to receiving execution information from the application, the first event unloader and the second event unloader are retrieved. The execution information is then written to the consumer target and the provider target using the first event unloader and the second event unloader respectively.

Sharing events and other metrics in native applications

The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides. The invention also relates to the treatment of diseases associated with reduced or increased levels of apoptosis using antibodies specific for DR4, which may be agonists and/or antagonists of DR4 activity.

Death domain containing receptor 4 antibodies and methods

Death domain containing receptor 4 antibody and methods

The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity.

Death domain containing receptor-4 agonist antibodies and methods

Death domain containing receptor-4 antibodies

The present invention relates to novel Death Domain Containing Receptor-4 (DR4) proteins which are members of the tumor necrosis factor (TNF) receptor family. In particular, isolated nucleic acid molecules are provided encoding the human DR4 proteins. DR4 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of DR4 activity and methods for using DR4 polynucleotides and polypeptides.

Death domain containing receptor 4

Death domain containing receptor-4

Death domain containing receptor 4 nucleic acids and methods

Growing community of inventors

Toronto, Canada

James G Pan